Jpmorgan Chase & CO Dynavax Technologies Corp Transaction History

Jpmorgan Chase & CO

  • $1.22 Trillion
  • Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Jpmorgan Chase & CO holds 205,447 shares of DVAX stock, worth $2.65 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
205,447
Previous 204,180 0.62%
Holding current value
$2.65 Million
Previous $2.29 Million 0.17%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Dec 26, 2024
BUY
$10.05 - $11.61 $12,733 - $14,709
1,267 Added 0.62%
205,447 $2.29 Million
Q3 2024

Nov 08, 2024
BUY
$10.05 - $11.61 $12,733 - $14,709
1,267 Added 0.62%
205,447 $2.29 Million
Q2 2024

Dec 26, 2024
SELL
$10.73 - $12.58 $13,594 - $15,938
-1,267 Reduced 0.62%
204,180 $2.29 Million
Q2 2024

Aug 12, 2024
SELL
$10.73 - $12.58 $3.39 Million - $3.98 Million
-316,105 Reduced 60.76%
204,180 $2.29 Million
Q1 2024

Dec 26, 2024
BUY
$11.7 - $14.98 $3.68 Million - $4.72 Million
314,838 Added 153.25%
520,285 $6.46 Million
Q1 2024

May 10, 2024
SELL
$11.7 - $14.98 $1.42 Million - $1.82 Million
-121,453 Reduced 18.93%
520,285 $6.46 Million
Q4 2023

Dec 26, 2024
BUY
$13.09 - $14.98 $5.71 Million - $6.54 Million
436,291 Added 212.36%
641,738 $8.97 Million
Q4 2023

Feb 12, 2024
BUY
$13.09 - $14.98 $4.99 Million - $5.71 Million
381,124 Added 146.24%
641,738 $8.97 Million
Q3 2023

Nov 14, 2023
BUY
$12.64 - $14.99 $22,107 - $26,217
1,749 Added 0.68%
260,614 $3.85 Million
Q2 2023

Aug 11, 2023
BUY
$9.85 - $13.17 $467,323 - $624,837
47,444 Added 22.44%
258,865 $3.34 Million
Q1 2023

May 18, 2023
BUY
$9.44 - $11.88 $1.41 Million - $1.78 Million
149,684 Added 242.45%
211,421 $2.07 Million
Q1 2023

May 11, 2023
SELL
$9.44 - $11.88 $1.05 Million - $1.32 Million
-111,310 Reduced 64.32%
61,737 $605,000
Q4 2022

Feb 13, 2023
BUY
$10.27 - $13.29 $197,553 - $255,646
19,236 Added 12.51%
173,047 $1.84 Million
Q3 2022

Nov 14, 2022
BUY
$9.93 - $17.44 $121,553 - $213,483
12,241 Added 8.65%
153,811 $1.61 Million
Q2 2022

Aug 11, 2022
BUY
$7.45 - $12.83 $437,098 - $752,748
58,671 Added 70.77%
141,570 $1.78 Million
Q1 2022

May 11, 2022
SELL
$9.75 - $14.44 $253,714 - $375,757
-26,022 Reduced 23.89%
82,899 $898,000
Q4 2021

Feb 10, 2022
BUY
$13.17 - $20.94 $568,983 - $904,670
43,203 Added 65.74%
108,921 $1.53 Million
Q3 2021

Nov 12, 2021
BUY
$9.16 - $19.83 $601,976 - $1.3 Million
65,718 New
65,718 $1.26 Million

Others Institutions Holding DVAX

# of Institutions
275
Shares Held
130M
Call Options Held
451K
Put Options Held
203K
View Full List

About DYNAVAX TECHNOLOGIES CORP

DVAX Quotes by TradingView
  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.63B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email